Medical Malpractice

Drug Manufacturers Hiding More Than Patients Know

Unsanitary conditions, and the truth behind labeling generic drugs

Just last month a Framingham, Mass., drug manufacturer, New England Compounding Center (NECC), unnecessarily infected more than 400 people across the nation because of a meningitis outbreak traced to a contaminated batch of steroids made by the lab. That outbreak has been linked to a reported 386 illnesses and 28 deaths according to the latest Centers for Disese Control and Prevention data.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to LexisAdvance®.

Continue to LexisAdvance®

Not a LexisAdvance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via LexisAdvance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202577927421

Thank you!

This article's comments will be reviewed.

Recommended for You